Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 12, 2019 07:30 ET | Source: T2 Biosystems, Inc.

T2 Biosystems to Highlight its Products and Technology at Upcoming Medical Meetings

LEXINGTON, Mass., June 12, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, announced...
June 10, 2019 07:30 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Reports Granting of Inducement Awards

LEXINGTON, Mass., June 10, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet...
June 06, 2019 07:30 ET | Source: T2 Biosystems, Inc.

New Studies Highlight Potential for T2Bacteria and T2Candida Panels to Improve Outcomes and be Cost-Effective for Sepsis Patients in the Medical Intensive Care Unit and Emergency Department

LEXINGTON, Mass., June 06, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, announced...
May 24, 2019 07:30 ET | Source: T2 Biosystems, Inc.

T2 Biosystems to Participate in Singular Research Spring Select Web Call

LEXINGTON, Mass., May 24, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, announced...
May 23, 2019 11:08 ET | Source: T2 Biosystems, Inc.

Robust Clinical Data and Positive Customer Experience with T2Bacteria and T2Candida Panels Highlighted at Recent Medical Meetings

Presentations at ECCMID and MAD-ID meetings demonstrate clinically actionable results and cost savings achieved with these panels Real-world experience reinforces multi-day time advantage...
May 14, 2019 07:00 ET | Source: T2 Biosystems, Inc.

Publication in Annals of Internal Medicine® Reveals T2Bacteria® Panel as the First Direct-from-Blood, Non-Culture Test that Rapidly Diagnoses Bacterial Bloodstream Infections

LEXINGTON, Mass., May 14, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, today...
May 13, 2019 16:30 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Reports Granting of Inducement Awards

LEXINGTON, Mass., May 13, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet...
May 08, 2019 14:45 ET | Source: T2 Biosystems, Inc.

T2 Biosystems to Showcase Breakthrough Rapid Diagnostics During 22nd Annual MAD-ID Meeting in Orlando, Florida

LEXINGTON, Mass., May 08, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative medical diagnostic products for critical unmet needs in...
May 02, 2019 16:01 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Reports First Quarter 2019 Financial Results and Provides Corporate Update

Exceeds Q1 Guidance with Delivery of $1.8 Million in Revenue and 11 New Instrument Contracts Confirms 2019 Guidance of a Doubling of Revenue and Securing 70 – 80 T2Dx Instrument Contracts LEXINGTON,...
April 18, 2019 16:30 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Announces 2019 First Quarter Financial and Operational Results Release and Conference Call Date

LEXINGTON, Mass., April 18, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative medical diagnostic products for critical unmet needs in...